| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
|
16,025 |
15,298 |
$1.34M |
| 99213 |
|
21,402 |
20,524 |
$1.15M |
| 87636 |
|
3,427 |
3,308 |
$417K |
| 87880 |
|
12,510 |
12,071 |
$157K |
| 87428 |
|
2,422 |
2,336 |
$128K |
| 99203 |
|
1,117 |
1,006 |
$94K |
| 87804 |
|
4,979 |
3,217 |
$90K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
798 |
767 |
$78K |
| 87811 |
|
1,489 |
1,428 |
$58K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,079 |
1,064 |
$55K |
| 99202 |
|
365 |
333 |
$23K |
| 99215 |
Prolong outpt/office vis |
64 |
64 |
$7K |
| 71045 |
|
623 |
607 |
$7K |
| 81001 |
|
2,541 |
2,444 |
$7K |
| 74018 |
|
197 |
189 |
$3K |
| 85027 |
|
501 |
477 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,599 |
2,493 |
$3K |
| 85025 |
|
412 |
396 |
$2K |
| 87807 |
|
183 |
175 |
$2K |
| 81025 |
|
327 |
315 |
$2K |
| 36415 |
|
925 |
881 |
$2K |
| 99212 |
|
33 |
32 |
$1K |
| 73630 |
|
33 |
33 |
$544.92 |
| 87210 |
|
119 |
107 |
$468.21 |
| 71046 |
|
25 |
25 |
$323.18 |
| 73610 |
|
15 |
15 |
$256.53 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
175 |
166 |
$174.83 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
13 |
12 |
$86.23 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
12 |
12 |
$0.00 |